Institution
Paris Descartes University
Government•Paris, France•
About: Paris Descartes University is a government organization based out in Paris, France. It is known for research contribution in the topics: Population & Immune system. The organization has 20987 authors who have published 37456 publications receiving 1206222 citations. The organization is also known as: Université Paris V-Descartes & Université de Paris V.
Topics: Population, Immune system, Cancer, Transplantation, Pregnancy
Papers published on a yearly basis
Papers
More filters
TL;DR: When performed with computerized magnetic resonance imaging-transrectal ultrasound image registration, targeted biopsy alone improved cancer detection over random biopsies, decreased the detection rate of microfocal cancer and increased the Detection rate of cancer with a Gleason score of greater than 6.
249 citations
University of Erlangen-Nuremberg1, Beth Israel Deaconess Medical Center2, French Institute of Health and Medical Research3, Paris Descartes University4, Wake Forest University5, University of Cyprus6, Charles University in Prague7, University of Texas Southwestern Medical Center8, University of Zurich9
TL;DR: Adopting a new terminology for this group of diseases using the term 'Autosomal Dominant Tubulointerstitial Kidney Disease' (ADTKD) appended by a gene-based subclassification, and suggests diagnostic criteria is anticipated to facilitate recognition and characterization of these monogenic diseases.
249 citations
TL;DR: The aim of this review is to describe the main advances in HCC in terms of molecular biology and to discuss how this knowledge could be used in clinical practice in the future.
248 citations
TL;DR: Campaigns to increase awareness combined with strategies to implement guideline recommendations will be crucial steps towards further optimizing management of acute PE, including the therapeutic implications of subsegmental PE.
248 citations
TL;DR: Initially used as a replacement therapy for immunodeficiency diseases, intravenous immunoglobulin (IVIg) is now widely used for a number of autoimmune and inflammatory diseases.
Abstract: Initially used as a replacement therapy for immunodeficiency diseases, intravenous immunoglobulin (IVIg) is now widely used for a number of autoimmune and inflammatory diseases. Considerable progress has been made in understanding the mechanisms by which IVIg exerts immunomodulatory effects in autoimmune and inflammatory disorders. The mechanisms of action of IVIg are complex, involving modulation of expression and function of Fc receptors, interference with activation of complement and the cytokine network and of idiotype network, regulation of cell growth, and effects on the activation, differentiation, and effector functions of dendritic cells, and T and B cells.
248 citations
Authors
Showing all 21023 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Guido Kroemer | 236 | 1404 | 246571 |
| Cyrus Cooper | 204 | 1869 | 206782 |
| Jean-Laurent Casanova | 144 | 842 | 76173 |
| Alain Fischer | 143 | 770 | 81680 |
| Maxime Dougados | 134 | 1054 | 69979 |
| Carlos López-Otín | 126 | 494 | 83933 |
| Giuseppe Viale | 123 | 740 | 72799 |
| Thierry Poynard | 119 | 668 | 64548 |
| Lorenzo Galluzzi | 118 | 477 | 71436 |
| Shahrokh F. Shariat | 118 | 1637 | 58900 |
| Richard E. Tremblay | 116 | 685 | 45844 |
| Olivier Hermine | 111 | 1026 | 43779 |
| Yehezkel Ben-Ari | 110 | 459 | 44293 |
| Loïc Guillevin | 108 | 800 | 51085 |
| Gérard Socié | 107 | 920 | 44186 |